Skip to content

Comparison of endothelial function by EndoPat® measurements in patients with primary Sjögren's syndrome to healthy controls and patients with systemic sclerosis

Comparison of endothelial function by EndoPat® measurements in patients with primary Sjögren's syndrome to healthy controls and patients with systemic sclerosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032430
Enrollment
110
Registered
2023-08-10
Start date
2023-09-13
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M35.0

Interventions

Group 1: In patients with primary Sjögren's syndrome, the endothelial function is checked once with an EndoPat measurement. In addition, a questionnaire interview (created specifically for the study)

Sponsors

Medizinische Hochschule Hannover
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Given consent with capacity to consent present. Meet current EULAR classification criteria for primary Sjögren's syndrome or systemic sclerosis.

Exclusion criteria

Exclusion criteria: current pregnancy not fulfilling the inclusion criteria lack of consent and capacity to consent Control patients must not have an underlying inflammatory disease

Design outcomes

Primary

MeasureTime frame
Endothelial function using RHI Detection of plaques in the common carotid artery, intima-media thickness of the common carotid artery, ankle-brachial index, pulse wave velocity of the common carotid artery and radial artery, and pulse wave analysis of the radial artery.

Secondary

MeasureTime frame
Comparison with disease severity and disease parameters using ESSDAI and ESSPRI; Comparison with disease-specific antibodies: ANA, RF, alpha-fodrin, Ro-AK, La-AK, hypergammaglobulinemia, IgG4 Cardiovascular risk factors, atherosclerotic end disease (CAD, pAD, stroke), disease activity, organ manifestations in pSS, evidence of novel biomarkers.

Countries

Germany

Contacts

Public ContactDiana Ernst

Medizinische Hochschule Hannover

Ernst.diana@mh-hannover.de+49 511 532 6656

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026